Brivaracetam Tablet
Product Images NDC 60505-4724

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Brivaracetam (NDC 60505-4724). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1000mg-btl-60s (100mg Btl 60s)

1000mg-btl-60s (100mg Btl 60s)
Label for Brivaracetam Tablets 100 mg oral tablets by Apotex Corp. The label indicates a quantity of 60 tablets and includes storage instructions, NDC 60505-4727-6, and pharmacist dispensing information. The label also shows manufacturer details for Apotex Inc., Toronto, Ontario, Canada, and Weston, Florida, USA.*
FDA Label Image

10mg-btl-60s (10mg Btl 60s)

10mg-btl-60s (10mg Btl 60s)
Brivaracetam 10 mg film-coated oral tablets packaging label. The label shows the quantity of 60 tablets and includes storage instructions, dosage caution, and a barcode. Manufactured by Apotex Corp., the label directs pharmacists to dispense the enclosed Medication Guide and notes the product is for prescription use only.*
FDA Label Image

25mg-btl-60s (25mg Btl 60s)

25mg-btl-60s (25mg Btl 60s)
Label for Brivaracetam Tablets 25 mg, an oral film-coated prescription tablet by Apotex Corp. The label indicates a package of 60 tablets, includes storage instructions (20°C to 25°C), and mentions dispensing a Medication Guide to each patient. The NDC code 60505-4724-6 is visible along with manufacturer details for Apotex Inc. in Toronto, Canada, and Apotex Corp. in Florida.*
FDA Label Image

50mg-btl-60s (50mg Btl 60s)

50mg-btl-60s (50mg Btl 60s)
Label for Brivaracetam 50 mg oral tablets by Apotex Corp. The label states the package contains 60 film-coated tablets. Manufacturer information includes Apotex Inc. in Toronto, Canada, and Apotex Corp. in Weston, Florida. Storage instructions and dispensing guidance are also present, along with a barcode and the NDC 60505-4725-6.*
FDA Label Image

75mg-btl-60s (75mg Btl 60s)

75mg-btl-60s (75mg Btl 60s)
Packaging label for Brivaracetam Tablets 75 mg, oral tablet form, in a 60 tablet count. The label shows the product name prominently along with the strength, manufacturer Apotex Corp., and storage instructions. It includes an NDC code 60505-4726-6 and a barcode, indicating prescription-only status.*
FDA Label Image

Figure_1 (Figure 1)

Figure_1 (Figure 1)
A bar chart showing the proportion of patients (%) by reduction in seizure frequency from baseline (%). It compares placebo and three doses of Brivaracetam (50 mg/day, 100 mg/day, 200 mg/day) across categories: Worse, 0 to <25%, 25 to <50%, 50 to <75%, and 75 to 100% seizure reduction.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Brivaracetam shown as a molecular diagram with atomic symbols and bonds. The image depicts the arrangement of carbon, nitrogen, oxygen, and hydrogen atoms in the Brivaracetam molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.